These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 32621027)
1. Prognostic performance of magnetic resonance imaging-guided biopsy in defining prostate cancer anterior lesions. Porreca A; Bianchi FM; Salvaggio A; D'Agostino D; Del Rosso A; Romagnoli D; Corsi P; Colicchia M; Barbaresi U; Bianchi L; Giampaoli M; Schiavina R; Palmer K; Del Giudice F; Maggi M; Ferro M; Sciarra A; De Berardinis E; Busetto GM World J Urol; 2021 May; 39(5):1473-1479. PubMed ID: 32621027 [TBL] [Abstract][Full Text] [Related]
2. The role of magnetic resonance imaging-guided biopsy for diagnosis of prostate cancer; comparison between FUSION and "IN-BORE" approaches. D'Agostino D; Casablanca C; Mineo Bianchi F; Corsi P; Romagnoli D; Giampaoli M; Fiori C; Schiavina R; Brunocilla E; Artibani W; Porreca A Minerva Urol Nephrol; 2021 Feb; 73(1):90-97. PubMed ID: 32456413 [TBL] [Abstract][Full Text] [Related]
3. Accuracy of Sampling PI-RADS 4-5 Index Lesions Alone by MRI-guided In-bore Biopsy in Biopsy-naive Patients Undergoing Radical Prostatectomy. Kilic M; Vural M; Coskun B; Acar Ö; Saglican Y; Akpek S; Esen T Eur Urol Focus; 2020 Mar; 6(2):249-254. PubMed ID: 31054811 [TBL] [Abstract][Full Text] [Related]
4. Additive Value of Transrectal Systematic Ventral Biopsies in Combination with Magnet Resonance Imaging/Ultrasound Fusion-Guided Biopsy in Patients with 3 or More Negative Prostate Biopsies. Maxeiner A; Nest AM; Stephan C; Cash H; Baur ADJ; Fischer T; Kilic E; Piper SK; Nowak CP; Busch J; Miller K; Mang J Urol Int; 2020; 104(3-4):205-213. PubMed ID: 31801153 [TBL] [Abstract][Full Text] [Related]
5. An initial negative round of targeted biopsies in men with highly suspicious multiparametric magnetic resonance findings does not exclude clinically significant prostate cancer-Preliminary experience. Costa DN; Kay FU; Pedrosa I; Kolski L; Lotan Y; Roehrborn CG; Hornberger B; Xi Y; Francis F; Rofsky NM Urol Oncol; 2017 Apr; 35(4):149.e15-149.e21. PubMed ID: 27939349 [TBL] [Abstract][Full Text] [Related]
6. Magnetic Resonance Imaging-guided In-bore and Magnetic Resonance Imaging-transrectal Ultrasound Fusion Targeted Prostate Biopsies: An Adjusted Comparison of Clinically Significant Prostate Cancer Detection Rate. Costa DN; Goldberg K; Leon AD; Lotan Y; Xi Y; Aziz M; Freifeld Y; Margulis V; Raj G; Roehrborn CG; Hornberger B; Desai N; Bagrodia A; Francis F; Pedrosa I; Cadeddu JA Eur Urol Oncol; 2019 Jul; 2(4):397-404. PubMed ID: 31277776 [TBL] [Abstract][Full Text] [Related]
7. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. Pokorny MR; de Rooij M; Duncan E; Schröder FH; Parkinson R; Barentsz JO; Thompson LC Eur Urol; 2014 Jul; 66(1):22-9. PubMed ID: 24666839 [TBL] [Abstract][Full Text] [Related]
8. Pathological findings at radical prostatectomy of biopsy naïve men diagnosed with MRI targeted biopsy alone without concomitant standard systematic sampling. Luzzago S; Petralia G; Maresca D; Sabatini I; Cordima G; Brescia A; Verweij F; Garelli G; Mistretta FA; Cioffi A; Pricolo P; Alessi S; Ferro M; Matei DV; Renne G; de Cobelli O; Musi G Urol Oncol; 2020 Dec; 38(12):929.e11-929.e19. PubMed ID: 32600928 [TBL] [Abstract][Full Text] [Related]
9. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen. Radtke JP; Schwab C; Wolf MB; Freitag MT; Alt CD; Kesch C; Popeneciu IV; Huettenbrink C; Gasch C; Klein T; Bonekamp D; Duensing S; Roth W; Schueler S; Stock C; Schlemmer HP; Roethke M; Hohenfellner M; Hadaschik BA Eur Urol; 2016 Nov; 70(5):846-853. PubMed ID: 26810346 [TBL] [Abstract][Full Text] [Related]
10. Direct comparison of multiparametric magnetic resonance imaging (MRI) results with final histopathology in patients with proven prostate cancer in MRI/ultrasonography-fusion biopsy. Borkowetz A; Platzek I; Toma M; Renner T; Herout R; Baunacke M; Laniado M; Baretton G; Froehner M; Zastrow S; Wirth M BJU Int; 2016 Aug; 118(2):213-20. PubMed ID: 26935133 [TBL] [Abstract][Full Text] [Related]